Evidence map›Paper›PMID 22355795›Full record

ReviewCold Spring Harbor perspectives in medicine2012

Vascular hyperpermeability, angiogenesis, and stroma generation.

Janice A Nagy, Ann M Dvorak, Harold F Dvorak

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 164 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Permissive role of vascular endothelium in fibrosis: focus on the kidney.American journal of physiology. Cell physiology · 2024
    Review
  9. Article
  10. Anticancer Activity of Region B Capsaicin Analogs.Journal of medicinal chemistry · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Enhancing Techniques for Determining Inflammatory Edema Formation and Neutrophil Accumulation in Murine Skin.JID innovations : skin science from molecules to population health · 2023
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Janice A NagyCenter for Vascular Biology Research and the Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA.
Ann M Dvorak
Harold F Dvorak
Harvard University · USBeth Israel Deaconess Medical Center · US

Funding

The Role of PlGF in Normal and Neoplastic AngiogenesisP01CA092644 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI DVORAK, HAROLD FISHER · 2002 to 2013
$17.2M
VEGFs in tumor lymphatic metastasisR01CA142262 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI DVORAK, HAROLD FISHER · 2009 to 2012
$1.8M
NCI NIH HHS P01 CA092644NCI NIH HHS P01 CA92644NCI NIH HHS R01 CA142262NCI NIH HHS R01CA42262
6 · The paper itself

Abstract

It has been known for more than half a century that the tumor microvasculature is hyperpermeable to plasma proteins. However, the identity of the leaky vessels and the consequences of vascular hyperpermeability have received little attention. This article places tumor vascular hyperpermeability in a broader context, relating it to (1) the low-level "basal" permeability of the normal vasculature; (2) the "acute," short-term hyperpermeability induced by vascular permeability factor/vascular endothelial growth factor (VPF/VEGF-A) and other vascular permeabilizing agents; and (3) the "chronic" hyperpermeability associated with longer-term exposure to agents such as VPF/VEGF-A that accompanies many types of pathological angiogenesis. Leakage of plasma protein-rich fluids is important because it activates the clotting system, depositing an extravascular fibrin gel provisional matrix that serves as the first step in stroma generation.

Indexed as

Biological AssayBlood Coagulation FactorsCapillary PermeabilityFibronectinsHumansImmunoglobulinsMicroscopy, Electron, TransmissionNeoplasmsNeovascularization, PathologicSerum AlbuminStromal CellsTerminology as TopicVascular Endothelial Growth Factor AVenulesBlood Coagulation FactorsFibronectinsImmunoglobulinsSerum AlbuminVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID22355795
PMCPMC3281587
OpenAlexW2114125544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.